F118L (p.Phe118Leu) variant of ABL2 (Tyrosine-protein kinase ABL2)
F118L (p.Phe118Leu) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
F118L (p.Phe118Leu) variant details
- p.Phe118Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.